Antidepressant effects of XXXX .

@entity172 @entity1 @entity162 @entity308 @entity4545 @entity1316 @entity2339 @entity2645 @entity3010 @entity1063
The authors present a case report that provides support for a relationship between @entity172 and the menstrual cycle on the 1 hand and @entity1316 on the other. The @entity1 in this case, a 35-year old @entity1 , suffered from a rapid cycling affective disorder that was severely affected by her menstrual cycle and responded positively to oral contraceptives (OCs). The @entity1 had a 24-year history of numerous manic and @entity308 episodes, the 1st of which coincided with menarche. She had noted that, 4 days before menses, she would experience symptoms of @entity3010 ( @entity3010 ) and often the onset of an affective episode. Treatment with a series of psychotropic agents had not been effective in controlling the number of episodes. However, the @entity1 reported that there had been an 8-9-month period in the past when she had taken OCs and had fewer symptoms. Thus, the @entity1 was placed on Ortho-Novum as well as @entity2645 . At the 9-month follow-up, she reported there had been no further episodes of @entity308 or @entity162 . The exact mechanism behind @entity172 's psychotropic effect is unclear, although it increases the central availability of @entity1063 and induces changes in dopaminergic, noradrenergic, and serotonergic receptors. @entity4545 levels covary with @entity172 levels, and @entity172 seems to affect every major neurotransmitter system. The fact that @entity172 has not consistently been shown to be effective in this regard may only signify the existence of a distinct subclass of @entity1316 closely linked to the menstrual cycle. This subclass may have some type of dysfunction within the @entity2339 that contributes to @entity1316 .
